Kasper S, Foch C, Messinger D, Esser R, et al. Noninferiority of cetuximab every-2-weeks versus standard once-weekly
administration schedule for the first-line treatment of RAS wild-type metastatic
colorectal cancer. Eur J Cancer 2020;144:291-301.
PMID: 33383349